Fair Isaac Corp: Form 10-Q for the period ended Mar 31, 2023
Filed with the SEC on Apr 27, 2023 and accepted by EDGAR at Apr 27, 2023, 20:16 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-01-01 to 2023-03-31 | $380.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2022-10-01 to 2023-03-31 | $725.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-01-01 to 2023-03-31 | $79.8m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2022-10-01 to 2023-03-31 | $156.4m | us-gaap:CostOfRevenue |
| Research and development | 3 months2023-01-01 to 2023-03-31 | $40.3m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2022-10-01 to 2023-03-31 | $76.9m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2023-01-01 to 2023-03-31 | $100.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2022-10-01 to 2023-03-31 | $193.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-01-01 to 2023-03-31 | $159.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2022-10-01 to 2023-03-31 | $300.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-01-01 to 2023-03-31 | $23.9m | us-gaap:InterestExpense |
| Interest expense | 6 months2022-10-01 to 2023-03-31 | $46.7m | us-gaap:InterestExpense |
| Income tax | 3 months2023-01-01 to 2023-03-31 | $35.9m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2022-10-01 to 2023-03-31 | $56.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-01-01 to 2023-03-31 | $101.5m | us-gaap:NetIncomeLoss |
| Net income | 6 months2022-10-01 to 2023-03-31 | $199.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-01-01 to 2023-03-31 | $4.00 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2022-10-01 to 2023-03-31 | $7.83 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-01-01 to 2023-03-31 | $4.04 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2022-10-01 to 2023-03-31 | $7.94 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-01-01 to 2023-03-31 | 25,419,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2022-10-01 to 2023-03-31 | 25,431,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2022-10-01 to 2023-03-31 | $182.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2022-10-01 to 2023-03-31 | $2.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months2022-10-01 to 2023-03-31 | $184.3m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-03-31 | $137.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-03-31 | $521.3m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-03-31 | $1.50bn | us-gaap:Assets |
| Current liabilities | At period end2023-03-31 | $373.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-03-31 | $2.27bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-03-31 | $1.82bn | us-gaap:LongTermDebt |
| Current portion of debt | At period end2023-03-31 | $107.0m | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2023-03-31 | −$770.8m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000814547-23-000008. Last ingested by Listed: Oct 24, 2026, 14:57 ET. Listed shows no prices and gives no investment advice.